H-CYTE, INC. - FORM 10-Q - EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - May 15, 2017

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - H-CYTE, INC.ex31-2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - H-CYTE, INC.ex31-1.htm
10-Q - FORM 10-Q - H-CYTE, INC.mdvx10q_mar312017.htm
 
EXHIBIT 32
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND 
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER 
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF 
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
  
 
Each of the undersigned, Jarrett Gorlin and Jeffery Wright, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended March 31, 2017, of MedoveX Corp. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: May 15, 2017
 
 
 
/s/ Jarrett Gorlin
 
Jarrett Gorlin,
 
Chief Executive Officer
 
 
 
 
 
 
 
/s/ Jeffery Wright
 
Jeffery Wright,
 
Chief Financial Officer
 
 

H-CYTE, INC. Reports